Multi-Modal Prediction of Extracorporeal Support—A Resource Intensive Therapy, Utilizing A Large National Database
Moderator
Presenter
Statement of Purpose
ECMO is a scarce, resource-intensive therapy, and the COVID-19 pandemic exposed substantial gaps in timely identification of candidates and equitable allocation. Prior work has largely relied on static risk scores or conventional machine-learning models built on snapshot data, offering limited ability to capture evolving physiology or to support continuous, anticipatory triage decisions. These approaches often underutilize multimodal EHR data and lack mechanisms to translate temporal dynamics into actionable early warnings.
Our work advances the field by introducing PreEMPT-ECMO, a hierarchical deep learning framework that fuses static features with multi-granularity time series to produce continuous predictions of ECMO utilization up to 96 hours in advance. Trained on a large, multicenter N3C cohort, the model outperforms established methods across time horizons and provides trajectory-aware interpretability to contextualize changing risk drivers. This capability aligns with real-world decision-making, enabling earlier triage and more judicious resource allocation; it also establishes a platform for prospective validation and extension beyond COVID-19 to broader refractory respiratory failure, including pediatric applications.
Learning Objectives
- Explain the limitations of static risk scores and how continuous, time-aware modeling can enhance early ECMO risk assessment and clinical decision-making.
Additional Information
Disclosures
Planning Committee
The planning committee and reviewers reported that they have no relevant financial relationship(s) with ineligible companies to disclose.
- Joanna Abraham, PhD, FACMI, FAMIA
- Jifan Gao, MS
- Frances Hsu, BS, MS
- Sonish Sivarajkumar
- Song Wang, MS
- Faisal Yaseen
Presenter
The following presenters have no relevant financial relationship(s) with ineligible companies to disclose.
- Daoyi Zhu, BS
AMIA Staff
The AMIA staff have no relevant financial relationship(s) with ineligible companies to disclose.
*All of the relevant financial relationships listed for these individuals have been mitigated.